Faktor Risiko Umur Lansia terhadap Kejadian Reaksi Obat yang Tidak Dikehendaki pada Pasien Hipertensi, Diabetes, Dislipidemia di Tiga Puskesmas di Kota Depok
AbstractTreatments in elderly patients are very complex and usually multiphatology thus causing an increase in number of polypharmacy for every clinical condition. The presence of hypertension, diabetes, and/or dyslipidemic will increase the risk of Adverse Drug Reaction (ADR) because of polypharmacy and long term of treatments. This study aimed to assess the effect of elderly age on the incidence of ADR in patients with hypertension, diabetes, and/or dyslipidemia at Puskesmas Pancoran Mas, Beji, and Tanah Baru in Depok. The design of the study is cohort study. The study was conducted at January-June 2014. Sixty two elderly patients were collected as cohort group and 62 non-elderly patients as control group. Subjects were monitored every week for a month. Clinical Manifestation of ADR event was an evaluation result of the recording complaints experienced by the subject using Naranjo scale. Clinical manifestation of ADR events obtained from both group were analyzed using Chi-square and Logistic Regression Test. This study found that 30,6% patients experienced ADR events with 39 times of accurrences. The most common clinical manifestation was dry cough related to the use of captopril (56,3%). The risk factor of ADR event in elderly age is 3,577 times greater than non-elderly age.
2. Abikusno N. Papers in population ageing. Older population in Indonesia: trends, issues, and policy responses. Bangkok: UNFPA Indonesia and Country Technical Services Team for East and South-East Asia; 2007
3. Sancar M, Mutlu BY, Okuyan B, Izzettin FV. Determination of geriatric patients' drug profile and identify their pharmaceutical care requirements by determining potential risk factors. European Geriatric Medicine. 2011;2(5):280–283
4. Stegemann S, Ecker F, Maio M, Kraahs P, Wohlfart R, Breitkreutz J, et al. Geriatric drug therapy: Neglecting the inevitable majority. Ageing Research Reviews. 2010;9(4):384–398
5. Ferner RE, Butt TF. Adverse drug reactions. Medicine Clinical Pharmacology. 2012;40(7):366-70.
6. Lövborg H, Eriksson LR, Jonsson AK, Bradley T, Hägg S. A prospective analysis of the preventability of adverse drug reactions reported in Sweden. European Journal of Clinical Pharmacology. 2012;68(8):1183-9.
7. Aslam M, Tan CK, Prayitno A. Farmasi klinis (clinical pharmacy), menuju pengobatan rasional dan penghargaan pilihan pasien. Jakarta: Elex Media Komputindo; 2003.
8. Christianie M, Setiati S, Trisna Y, Andrajati R. Kejadian reaksi obat yang tidak dikehendaki yang menyebabkan pasien usia lanjut dirawat di ruang perawatan penyakit dalam instalasi rawat inap B Rumah Sakit Dr. Cipto Mangunkusumo. Majalah Ilmu Kefarmasian. 2008;5(3):138-149.
9. Hajjar ER, Hanlom JT, Artz MB, Lindblad CI, Pieper CF, Sloane RJ, et al. Adverse drug reactions in older outpatients. The American Journal of Geriatric Pharmacotherapy. 2003;1(2):82-89.
10. Mandavi, D’Cruz S, Sachdev A, Tiwari P. Adverse drug reactions & their risk factors among Indian ambulatory elderly patients. Indian Journal of Medical Research. 2012;136(3): 404–410.
11. Hamilton H, Gallagher P, Ryan C, Byrne S, O’Mahony D. Potentially inappropriate medications defined by STOPP criteria and risk of adverse drug evens in older hospitalized patients. Archives of International Medicine. 2011;171(11): 1013-1019.
12. Obreli-Neto PR, Nobili A, Baldoni AO, Guidoni CM, Junior DPL, Pilger D, et al. Adverse drug reactions caused by drug-drug interactions in elderly outpatients: a prospective cohort study. European Journal of Clinical Pharmacology. 2012;68(12):1667-76.
13. Republik Indonesia. Peraturan Menteri Kesehatan RI Nomor 30 Tahun 2014 tentang Standar Pelayanan Kefarmasian di Puskesmas. Jakarta: Kementerian Kesehatan; 2014.
14. Badan Pusat Statistik Kota Depok. Depok dalam angka 2010. Depok: BPS Kota Depok; 2012.
15. Dinkes Kota Depok. Profil kesehatan kota Depok tahun 2008. Depok: Dinas Kesehatan Kota Depok; 2008.
16. Low S, Chin MC, Ma S, Heng D, Deurenberg-Yap M. Rationale for redefining obesity in Asians. Annals of the Academy of Medicine Singapore. 2009;38(1):66–9.
17. Omboni S, Borghi C. Zofenopril and incidence of cough: a review of published and unpublished data. Therapeutics and Clinical Risk Management. 2011;7:459-471.
18. Scott S, Thompson J. Adverse drug reactions. Anaesthesia and Intensive Care Medicine. 2011;12(7):319-23.
19. O’Connor MN, Gallagher P, Byrne S, O’Mahony D. Adverse drug reactions in older patients during hospitalisation: are they predictable?. Age and Ageing. 2012;41(6):771-6.
Copyright (c) 2016 Jurnal Kefarmasian Indonesia
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.